Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use
Sign Up to like & getrecommendations! Published in 2020 at "Patient preference and adherence"
DOI: 10.2147/ppa.s203614
Abstract: Abstract Endocrinological changes that occur with menopause lead to a chronic and progressive condition named vulvar and vaginal atrophy (VVA). This disease is characterized by symptoms such as dryness, dyspareunia, itching, burning, and dysuria. According… read more here.
Keywords: patient; ospemifene management; vaginal atrophy; vulvar vaginal ... See more keywords